Goodbody Health Inc. (CSE:GDBY) ("Goodbody Health" or the "Company") is pleased to announce a new sponsorship agreement with James Hedley for the Formula GB3 2022 Season. The Company Sponsored James in the 2019 Ginetta Junior Season following his win in the 2018 Ginetta Junior Winter Series Championship. He went on to become the 2019 Ginetta Junior Champion before moving onto Formula 4 in 2020 and 2021.

In Formula 4, as well as continuing to get wins and podiums, James won the Thruxton triple crown, a unique record. James is a British Racing Drivers Club ("BRDC") Rising Star and has won the prestigious Peter Collins Trophy for most outstanding driver.

All 24 rounds of the GB3 Championship are broadcast free to air by leading UK television network: ITV. An hour show is screened in a prime-time Sunday evening slot on ITV4 and ITV4HD which features highlights of every race weekend's three races as well as the pre-race build up, podium celebrations, post-race interviews and behind-the-scenes features on the drivers.

Geremy Thomas, Executive Chairman, said; "We are absolutely delighted to be sponsoring James. Sportsmen and women know how important understanding and managing their health is and therefore this is a perfect partnership for the Company."

The Directors of the Company accept responsibility for the contents of this announcement.

On behalf of the Board of Directors,

Marc Howells
Chief Executive Officer
Goodbody Health Inc.
+44 (0) 20 7971 1255
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.goodbodyhealth.com

Anne Tew
Chief Financial Officer
Goodbody Health Inc.
+44 (0) 20 7971 1255
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.goodbodyhealth.com

Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release. This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Goodbody Health's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" "plan is" or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur", "will be achieved" or "shortly". Although Goodbody Health believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this press release, and Goodbody Health does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

SOURCE: Goodbody Health Inc.